DocGo (DCGO) Net Income towards Common Stockholders (2020 - 2026)

DocGo's Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$16.7 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 77.56% year-over-year to -$16.7 million; the TTM figure through Mar 2026 stood at -$202.0 million (down 31429.98% YoY), while the FY2025 annual figure was -$196.4 million, down 1082.22% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$16.7 million, up from -$142.3 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $12.7 million in Q2 2022, with the low at -$142.3 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is $3.2 million (2022), against an average of -$8.8 million.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders soared 873.63% in 2022, then sank 4262.52% in 2025.
• DocGo's Net Income towards Common Stockholders stood at $8.1 million in 2022, then slipped by 6.13% to $7.6 million in 2023, then tumbled by 143.1% to -$3.3 million in 2024, then tumbled by 4262.52% to -$142.3 million in 2025, then soared by 88.27% to -$16.7 million in 2026.
• Business Quant data shows DCGO's Net Income towards Common Stockholders at -$16.7 million in Q1 2026, -$142.3 million in Q4 2025, and -$29.7 million in Q3 2025.